-1722511478674.svg){kind=small}
Published 20:22 IST, July 27th 2024
Dr Reddy's Q1 profit marginally declines to Rs 1,392 crore; revenue rises to Rs 7,673 crore
The revenue from the North American generics business saw a significant year-on-year increase, rising 20% to Rs 3,846 crore for the first quarter.
Dr Reddy's Laboratories Q3 results | Image:
Dr Reddy's Laboratories
Advertisement
20:22 IST, July 27th 2024